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Microsatellite instability (MSI) results from defective DNA 
produced as an end result of mismatch. Approximately 
12–18% of colorectal carcinomas show MSI. MSI is 
the result of defects in genes hMLH1, hMSH2, hPMS1, 
hPMS2 and GTBP/hMSH6.[1] Tumours which have MSI 
are called MSI-H. MSI-H tumours are significant predictors 
of disseminated disease in colorectal cancer.[2] Tumours on 
the right side of colon (caecum/ascending colon), those in 
patients younger than 50 years and those with medullary or 
signet ring morphology are suggestive of mismatch repair 
(MMR) loss and should be screened for MMR proteins by 
immunohistochemistry (IHC). The results of IHC should 
be interpreted and subsequently followed up as follows:
• All four proteins are present and there is no family 
history (80% of total cases): Stop further testing.
• MLH 1 and PMS 2 are absent (15% of total cases): 
Check for BRAF mutation analysis: If present, stop 
testing: If negative, sequence for gene rearrangement.
• MSH 2 and/or MSH 6 absent (5% of total cases): 
Sequence for gene rearrangement.
Positive staining demonstrates that the tumour is negative 
for MSI. A negative staining would mean tumour is MSI 
high or microsatellite unstable.
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Figure 1: The figure shows adenocarcinoma of rectum, 
moderately differentiated, hematoxylin and eosin stained slide 
at ×40 magnification. Immunohistochemical stain MLH 1 (inset) 
shows positive staining in the tumour cells as well as benign 
epithelial cells (acting as positive internal control)
